These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 20453667

  • 1. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
    Rubattu S, Barbato A, Marchitti S, Iacone R, Di Castro S, Evangelista A, Stanzione R, Ippolito R, Sciarretta S, Palmieri L, Volpe M, Strazzullo P, Olivetti Heart Study Research Group.
    J Hypertens; 2010 Aug; 28(8):1638-45. PubMed ID: 20453667
    [Abstract] [Full Text] [Related]

  • 2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 3. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R, Iordanova N, Jarai R, Raffetseder A, Woloszczuk W, Gyöngyösi M, Geyer G, Wojta J, Huber K.
    Eur Heart J; 2005 Feb 13; 26(3):250-6. PubMed ID: 15618049
    [Abstract] [Full Text] [Related]

  • 4. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
    Rubattu S, Sciarretta S, Ciavarella GM, Venturelli V, De Paolis P, Tocci G, De Biase L, Ferrucci A, Volpe M.
    J Hypertens; 2007 Apr 13; 25(4):833-9. PubMed ID: 17351376
    [Abstract] [Full Text] [Related]

  • 5. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study.
    Levy D, Hwang SJ, Kayalar A, Benjamin EJ, Vasan RS, Parise H, Larson MG, Wang TJ, Selhub J, Jacques PF, Vita JA, Keyes MJ, Mitchell GF.
    Circulation; 2007 Jun 19; 115(24):3079-85. PubMed ID: 17533184
    [Abstract] [Full Text] [Related]

  • 6. Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
    Melander O, Frandsen E, Magnusson M, Grubb A, Jovinge S, Groop L.
    J Intern Med; 2005 Mar 19; 257(3):281-8. PubMed ID: 15715685
    [Abstract] [Full Text] [Related]

  • 7. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
    Kouloubinis A, Kaklamanis L, Ziras N, Sofroniadou S, Makaritsis K, Adamopoulos S, Revela I, Athanasiou A, Mavroudis D, Georgoulias V.
    Int J Cardiol; 2007 Nov 30; 122(3):195-201. PubMed ID: 17289172
    [Abstract] [Full Text] [Related]

  • 8. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U, Brueckmann M, Bertsch T, Wiessner M, Liebetrau C, Lang S, Haase KK, Borggrefe M, Huhle G.
    Clin Lab; 2005 Nov 30; 51(7-8):373-9. PubMed ID: 16122147
    [Abstract] [Full Text] [Related]

  • 9. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
    Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS.
    N Engl J Med; 2004 Feb 12; 350(7):655-63. PubMed ID: 14960742
    [Abstract] [Full Text] [Related]

  • 10. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
    Andersson B, Hall C.
    J Card Fail; 2000 Sep 12; 6(3):208-13. PubMed ID: 10997746
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the association between plasma concentration of N-terminal proatrial natriuretic peptide and outcome in cats with cardiomyopathy.
    Zimmering TM, Hungerbühler S, Meneses F, Nolte I, Simon D.
    J Am Vet Med Assoc; 2010 Sep 15; 237(6):665-72. PubMed ID: 20839988
    [Abstract] [Full Text] [Related]

  • 12. Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease.
    Lalor SM, Connolly DJ, Elliott J, Syme HM.
    J Vet Cardiol; 2009 May 15; 11 Suppl 1():S71-9. PubMed ID: 19398225
    [Abstract] [Full Text] [Related]

  • 13. Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age.
    Holmström H, Hall C, Stokke TO, Thaulow E.
    Scand J Clin Lab Invest; 2000 Apr 15; 60(2):149-59. PubMed ID: 10817402
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 17. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function.
    Nishikimi T, Mori Y, Ishimura K, Tadokoro K, Yagi H, Yabe A, Horinaka S, Matsuoka H.
    Am J Med; 2004 Apr 15; 116(8):517-23. PubMed ID: 15063812
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.
    J Hypertens; 2008 Jan 15; 26(1):26-34. PubMed ID: 18090537
    [Abstract] [Full Text] [Related]

  • 20. Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men.
    Laukkanen JA, Kurl S, Ala-Kopsala M, Vuolteenaho O, Ruskoaho H, Nyyssönen K, Salonen JT.
    Eur Heart J; 2006 May 15; 27(10):1230-7. PubMed ID: 16621869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.